J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):377-383. doi: 10.4103/0973-029X.190906.
Sonic hedgehog in oral squamous cell carcinoma: An immunohistochemical study.
Journal of oral and maxillofacial pathology : JOMFP
Sahana Srinath, Asha R Iyengar, Vijaya Mysorekar
Affiliations
Affiliations
- Department of Oral Pathology, GDCRI, Bengaluru, Karnataka, India.
- Department of Oral Medicine and Radiology, DAPMRV, Bengaluru, Karnataka, India.
- Department of Pathology, MSRMC, Bengaluru, Karnataka, India.
PMID: 27721600
PMCID: PMC5051283 DOI: 10.4103/0973-029X.190906
Abstract
BACKGROUND: Recent studies have revealed the involvement of hedgehog (Hh) signaling component in proliferation and invasive behavior of many carcinomas.
AIM: This study aims to identify the expression of sonic Hh (SHH) protein of SHH pathway in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC) using SHH (H-160) (Santa Cruz, sc-9042) which could have therapeutic implication in future.
MATERIALS AND METHODS: A total of 250 cases comprising 50 normal oral mucosa, 50 cases of oral epithelial dysplasia, 50 well, 50 moderate and 50 poorly differentiated OSCCs were included in the study. Immunohistochemical evaluation of SHH protein expression was conducted using monoclonal antibody. Interpretation of the expression was done by immunoreactive score of Remmele and Stegner (IRS) scoring method.
STATISTICAL ANALYSIS: Chi-Square test was used to analyze the results.
RESULTS: The study showed that SHH signaling molecules are highly expressed in OSCC, and their expression was mainly in the cytoplasm of epithelial cells.
CONCLUSION: The SHH signaling component is associated with the pathological parameter in OSCC and oral epithelial dysplasia.
Keywords: Dysplasia; oral squamous cell carcinoma; sonic hedgehog
References
- Cell. 1996 Nov 1;87(3):553-63 - PubMed
- Nature. 2008 Sep 18;455(7211):406-10 - PubMed
- Cell. 1989 Nov 17;59(4):751-65 - PubMed
- Head Neck Oncol. 2009 Oct 14;1:36 - PubMed
- J Dent Res. 2012 Apr;91(4):334-40 - PubMed
- Hum Pathol. 2011 Oct;42(10):1484-90 - PubMed
- Dermatology. 2004;209(2):126-31 - PubMed
- Mol Cancer Ther. 2009 Feb;8(2):310-4 - PubMed
- J Exp Clin Cancer Res. 2014 Apr 24;33:34 - PubMed
- Gastroenterology. 2009 Sep;137(3):1102-13 - PubMed
- Stem Cells Int. 2013;2013:319489 - PubMed
- J Clin Oncol. 2011 Nov 10;29(32):4294-301 - PubMed
- Head Neck. 2011 Feb;33(2):244-50 - PubMed
- Adv Exp Med Biol. 2012;727:305-19 - PubMed
- Lancet Oncol. 2010 Aug;11(8):781-9 - PubMed
- J Oral Pathol Med. 2010 Apr;39(4):299-305 - PubMed
- Genes Dev. 2001 Dec 1;15(23):3059-87 - PubMed
- N Engl J Med. 2009 Sep 17;361(12 ):1164-72 - PubMed
- Am J Med Genet A. 2003 Nov 15;123A(1):5-28 - PubMed
- Oral Oncol. 2011 Apr;47(4):237-43 - PubMed
- Oral Oncol. 2012 Jan;48(1):1-9 - PubMed
- Head Neck Pathol. 2007 Sep;1(1):61-6 - PubMed
- Cell. 1996 Jul 26;86(2):221-32 - PubMed
- Cancers (Basel). 2015 Mar 31;7(2):585-97 - PubMed
- Mayo Clin Proc. 2008 Apr;83(4):489-501 - PubMed
- Oral Oncol. 2013 Sep;49(9):854-62 - PubMed
- ChemMedChem. 2010 Apr 6;5(4):500-12 - PubMed
- Biochim Biophys Acta. 2013 Feb;1830(2):2481-95 - PubMed
- Lancet. 2008 May 17;371(9625):1695-709 - PubMed
- Asian Pac J Cancer Prev. 2011;12(6):1561-6 - PubMed
- CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
- Head Neck. 2012 Nov;34(11):1556-61 - PubMed
- Onkologie. 2013;36(5):279-86 - PubMed
- Cell Mol Life Sci. 2011 Dec;68(24):4009-22 - PubMed
- Nat Rev Cancer. 2008 Oct;8(10):755-68 - PubMed
Publication Types